ScholarIQanswers from OpenAlex

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy

PaperCitations, authors & open-access status

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy have?

ScholarIQcitation count

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy has 72 citations in the OpenAlex counts ScholarIQ stores.

When was Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy published?

ScholarIQyear

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy has 2015 year in the ScholarIQ index.

What is the open-access status of Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy?

ScholarIQoa status

Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy has diamond oa status in the ScholarIQ index.

What is the DOI of Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy?

ScholarIQdoi

The DOI for Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy is on the source record.

What is the PMID of Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy?

ScholarIQpmid

The PMID for Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy is on the source record.

What is the OpenAlex record for Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy?

ScholarIQopenalex

The OpenAlex for Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial